Anybody that follows me here on "X", WITH #MultipleSclerosis happen to live in or within 30 miles of @charlottenc --- If yes, send a direct message to me, please, before end of the day today .. - Thank you
A new @JohnsHopkins trial, TAG-MS, is exploring if pegsebrenatide can slow neurodegeneration in those living with #MultipleSclerosis. This treatment targets the GLP-1 receptor & early evidence suggests this class of drugs may have protective effects within the brain & CNS. [1/2]
TODAY at 7pm ET with @AaronBosterMD - Discussion on MS Diagnosis, MS relapse and MRI --
Join us for MS views NOW- https://t.co/8zO2eMDA8l
-----------------------
#multiplesclerosis
In MS research, there is a strong correlation between preventing relapses and preventing disability progression, but these authors argue tolebrutinib is unique in that it prevents progression out of proportion to its ability to prevent relapses https://t.co/n1JdwqJkGU